Strategies for dose reduction with specific clinical indications during computed tomography

dc.contributor.authorJoyce, Stella
dc.contributor.authorO'Connor, Owen J.
dc.contributor.authorMaher, Michael M.
dc.contributor.authorMcEntee, Mark F.
dc.date.accessioned2020-12-02T16:23:45Z
dc.date.available2020-12-02T16:23:45Z
dc.date.issued2020-07-15
dc.date.updated2020-11-23T12:50:43Z
dc.description.abstractIncreasing integration of computed tomography (CT) into routine patient care has escalated concerns regarding associated radiation exposure. Specific patient cohorts, particularly those with cystic fibrosis (CF) and Crohn's disease, have repeat exposures and thus have an increased risk of high lifetime cumulative effective dose exposures. Thoracic CT is the gold standard imaging method in the diagnosis, assessment and management of pulmonary disease. In the setting of CF, CT demonstrates increased sensitivity compared with pulmonary function tests and chest radiography. Furthermore, in specific cases of Crohn's disease, CT demonstrates diagnostic superiority over magnetic resonance imaging (MRI) for radiological evaluation. Low dose CT protocols have proven beneficial in the evaluation of CF, Crohn's disease and renal calculi, and in the follow up of testicular cancer patients. For individuals with chronic conditions warranting frequent radiological follow up, the focus must continue to be the incorporation of appropriate CT use into patient care. This is of particular importance for the paediatric population who are most susceptible to potential radiation induced malignancy. CT technological developments continue to focus on radiation dose optimisation. This article aims to highlight these advancements, which prioritise the acquisition of diagnostically satisfactory images with the least amount of radiation possible.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationJoyce, S., O'Connor, O. J., Maher, M. M. and McEntee, M. F. (2020) 'Strategies for dose reduction with specific clinical indications during computed tomography', Radiography, 26, pp. S62-S68. doi: 10.1016/j.radi.2020.06.012en
dc.identifier.doi10.1016/j.radi.2020.06.012en
dc.identifier.endpageS68en
dc.identifier.issn1078-8174
dc.identifier.journaltitleRadiographyen
dc.identifier.startpageS62en
dc.identifier.urihttps://hdl.handle.net/10468/10808
dc.identifier.volume26en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S1078817420301000
dc.rights© 2020 The Authors. Published by Elsevier Ltd on behalf of The College of Radiographers. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectCrohn's diseaseen
dc.subjectCTen
dc.subjectCystic fibrosisen
dc.subjectDose reductionen
dc.titleStrategies for dose reduction with specific clinical indications during computed tomographyen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
dose_reduction_strategies.pdf
Size:
534.81 KB
Format:
Adobe Portable Document Format
Description:
Published version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: